V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003488 | 210009063 | 1.58 | 76 | null | null | 2018-09-26 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100619331 |
| 210003491 | 210009066 | 1.58 | 86.6 | Neo-adjuvant (N) | 2018-11-16 | 2019-02-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100591677 |
| 210003493 | 210009067 | 1.5 | 63.8 | null | 2022-04-16 | 2022-04-17 | Capecitabine | null | null | CAPECITABINE | 101844490 |
| 210003495 | 210009068 | 1.61 | 96.6 | Palliative (P) | null | 2019-04-01 | Capecitabine | 02 | N | CAPECITABINE | 100170841 |
| 210003497 | 210009069 | 1.7 | 71 | Neo-adjuvant (N) | 2018-08-24 | 2018-08-31 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101680730 |
| 210003501 | 210009071 | null | null | null | null | 2016-10-10 | null | null | null | EC | 101043228 |
| 210003502 | 210009072 | null | null | Adjuvant (A) | null | 2018-07-06 | Capecitabine | null | N | PACLITAXEL + TRASTUZUMAB | 100410458 |
| 210003506 | 210009075 | 1.72 | 96.7 | Adjuvant (A) | 2018-07-21 | 2018-07-21 | EC | N | N | EC | 100935051 |
| 210003512 | 210009078 | 1.73 | 86.7 | null | 2017-06-22 | 2017-09-08 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101860377 |
| 210003515 | 210009080 | 1.66 | 78.7 | Palliative (P) | 2018-07-17 | 2018-09-27 | null | 01 | N | EC | 100708990 |
| 210003517 | 210009081 | null | null | null | 2021-12-01 | 2021-12-01 | FEC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100215560 |
| 210003521 | 210009083 | 1.69 | 84 | null | null | 2020-07-16 | Everolimus 10mg | 02 | null | NAB-PACLITAXEL | 100132424 |
| 210003525 | 210009085 | 1.66 | 59.3 | null | 2019-11-29 | 2019-11-29 | VINORELBINE | 02 | null | CAPECITABINE | 100811853 |
| 210003530 | 210009087 | 1.65 | 54.7 | Palliative (P) | 2016-06-15 | 2016-09-07 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101298612 |
| 210003532 | 210009088 | null | null | Adjuvant (A) | 2018-04-28 | 2018-05-02 | null | 02 | N | EC | 100669115 |
| 210003533 | 210009089 | 1.59 | null | Neo-adjuvant (N) | 2017-03-27 | 2017-06-06 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100241636 |
| 210003534 | 210009090 | null | null | null | 2018-12-22 | 2019-01-12 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100107612 |
| 210003536 | 210009091 | null | 70.8 | Neo-adjuvant (N) | 2018-06-08 | 2018-08-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101491473 |
| 210003542 | 210009096 | 1.55 | 89.15 | null | 2019-11-28 | 2020-01-11 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101043355 |
| 210003543 | 210009097 | 1.51 | 60.5 | null | 2021-12-22 | 2022-01-06 | null | N | null | CAPECITABINE | 100446136 |
| 210003544 | 210009098 | null | 76.9 | Adjuvant (A) | 2021-09-05 | 2021-09-13 | null | 02 | null | PALBOCICLIB | 101027596 |
| 210003548 | 210009101 | 1.6 | 52.8 | null | null | 2020-05-31 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100525179 |
| 210003554 | 210009103 | null | 64.3 | null | 2018-02-04 | 2018-02-06 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 101431938 |
| 210003555 | 210009104 | 1.77 | 60.8 | Palliative (P) | 2020-03-27 | 2020-06-14 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 100982237 |
| 210003556 | 210009105 | 1.68 | 67.9 | Palliative (P) | 2017-06-05 | 2017-06-14 | null | 02 | N | EPIRUBICIN | 100530539 |
| 210003559 | 210009106 | null | null | null | 2018-08-16 | 2019-11-17 | Letrozole + Palbociclib | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101602883 |
| 210003560 | 210009107 | null | null | null | null | 2018-01-04 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 101628277 |
| 210003561 | 210009108 | 1.61 | null | null | 2016-10-25 | 2016-12-13 | FEC | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100160981 |
| 210003562 | 210009109 | 1.59 | 109.6 | null | null | 2019-10-13 | null | 01 | null | PACLITAXEL + TRASTUZUMAB | 101857054 |
| 210003564 | 210009111 | 1.61 | 78.1 | Neo-adjuvant (N) | 2017-09-24 | 2018-01-26 | FEC | 02 | N | LETROZOLE + PALBOCICLIB | 100430523 |
| 210003571 | 210009116 | null | null | null | 2021-08-28 | 2021-09-11 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101595631 |
| 210003579 | 210009120 | 1.57 | 90.7 | null | null | 2019-08-04 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 100932031 |
| 210003580 | 210009121 | 1.6 | 116.2 | Adjuvant (A) | 2019-09-02 | 2019-09-03 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL + Pertuzumab + Trastuzumab | N | N | TCH | 101198518 |
| 210003582 | 210009123 | 1.54 | 85.4 | Palliative (P) | 2017-02-05 | 2017-02-19 | TCH (21 day Trastuzumab) Maint | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101592335 |
| 210003584 | 210009124 | 1.66 | 77.2 | 03 | 2019-04-23 | 2019-08-05 | null | null | N | PALBOCICLIB | 100337815 |
| 210003587 | 210009125 | null | 88.5 | Adjuvant (A) | 2020-05-22 | 2020-07-25 | Capecitabine | 02 | N | CAPECITABINE | 100491534 |
| 210003588 | 210009126 | 1.63 | 68.08 | null | 2018-10-24 | 2018-11-16 | TRASTUZUMAB EMTANSINE | N | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100005171 |
| 210003591 | 210009128 | null | null | null | null | 2016-09-23 | CARBOPLATIN + PACLITAXEL | 02 | null | LETROZOLE + PALBOCICLIB | 100654769 |
| 210003592 | 210009129 | 1.64 | 84 | Palliative (P) | 2016-04-02 | 2016-04-24 | EVEROLIMUS | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100779494 |
| 210003594 | 210009131 | 1.62 | 77.4 | Adjuvant (A) | 2015-08-27 | 2018-06-11 | Fulvestrant + Palbociclib | null | null | CYCLO + DOCETAXEL + TRASTUZUMAB | 101091458 |
| 210003599 | 210009135 | 1.69 | 73.7 | null | 2020-02-13 | 2020-05-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100756826 |
| 210003602 | 210009138 | null | null | Adjuvant (A) | 2022-01-29 | 2022-04-18 | Paclitaxel albumin (Abraxane) 21day | null | N | PACLITAXEL + TRASTUZUMAB | 101661219 |
| 210003607 | 210009140 | 1.52 | 53.8 | Adjuvant (A) | 2018-07-14 | 2018-07-15 | Capecitabine | null | null | CAPECITABINE | 100594441 |
| 210003610 | 210009143 | 1.72 | 76.6 | Curative (C) | null | 2018-10-17 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101694091 |
| 210003611 | 210009144 | 1.64 | 55.4 | null | null | 2018-01-01 | EC | 02 | null | EC | 100541136 |
| 210003612 | 210009145 | 1.46 | null | null | 2017-06-16 | 2017-06-19 | null | null | null | SACITUZUMAB GOVITECAN | 100548100 |
| 210003613 | 210009146 | 1.62 | 60 | null | null | 2017-10-30 | null | null | null | CAPECITABINE | 100164255 |
| 210003614 | 210009147 | 1.54 | 55.45 | null | 2018-01-29 | 2018-04-22 | GEMCARBO | null | null | EC | 100051436 |
| 210003618 | 210009151 | null | 72.7 | null | null | 2019-12-03 | Capecitabine + Docetaxel | 02 | null | EC | 100146049 |
| 210003620 | 210009153 | 1.66 | 74 | null | 2019-12-23 | 2020-01-02 | null | N | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101692920 |